Repeated decrease of CD4+ T-cell counts in patients with rheumatoid arthritis over multiple cycles of rituximab treatment View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-12

AUTHORS

Matthieu Lavielle, Denis Mulleman, Philippe Goupille, Clément Bahuaud, Hsueh Cheng Sung, Hervé Watier, Gilles Thibault

ABSTRACT

BACKGROUND: Significant peripheral blood CD4+ T-cell depletion has been observed after a first cycle of rituximab, a monoclonal antibody directed against the CD20 antigen, which is currently used in rheumatoid arthritis. Of note, an absence of CD4+ T-cell decrease has been observed in non-responders. Herein, we describe CD4+ T-cell changes over repeated cycles of rituximab and their relationship with clinical outcomes. METHODS: Patients with rheumatoid arthritis who started rituximab between July 2007 and July 2013 were analyzed up to November 2014. Lymphocyte phenotyping and clinical assessments were performed before, and 3 and 6 months after each cycle. Lymphocytes counts and disease activity were compared at each time point, using nonparametric tests. RESULTS: Patients received up to seven cycles of treatment during the study period. Mean CD4+ T-cell counts were above the upper limit of the reference range before each rituximab infusion and repeatedly reached the reference range at 6 months (and/or 3 months) post infusion. CD4+ T cells decreased concurrently with disease activity score. CONCLUSIONS: CD4+ T-cell counts could be a relevant biomarker of response to rituximab in rheumatoid arthritis and could be considered in making decisions about the timing of retreatment. More... »

PAGES

253

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s13075-016-1152-5

DOI

http://dx.doi.org/10.1186/s13075-016-1152-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1001472369

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27793209


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antirheumatic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Arthritis, Rheumatoid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "CD4 Lymphocyte Count", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "CD4-Positive T-Lymphocytes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Flow Cytometry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rituximab", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire de Tours", 
          "id": "https://www.grid.ac/institutes/grid.411167.4", 
          "name": [
            "Universit\u00e9 Fran\u00e7ois-Rabelais de Tours, CNRS, UMR 7292, Tours, France", 
            "Service de Rhumatologie, CHRU de Tours, Tours, France", 
            "Laboratoire d\u2019Immunologie, CHRU de Tours, Tours, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lavielle", 
        "givenName": "Matthieu", 
        "id": "sg:person.011675334345.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011675334345.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire de Tours", 
          "id": "https://www.grid.ac/institutes/grid.411167.4", 
          "name": [
            "Universit\u00e9 Fran\u00e7ois-Rabelais de Tours, CNRS, UMR 7292, Tours, France", 
            "Service de Rhumatologie, CHRU de Tours, Tours, France", 
            "GICC \u2013 UMR 7292, UFR de M\u00e9decine, B\u00e2timent Vialle, 10 boulevard Tonnell\u00e9, BP 3223, 37032, Tours, Cedex 01, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mulleman", 
        "givenName": "Denis", 
        "id": "sg:person.01272504637.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272504637.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire de Tours", 
          "id": "https://www.grid.ac/institutes/grid.411167.4", 
          "name": [
            "Universit\u00e9 Fran\u00e7ois-Rabelais de Tours, CNRS, UMR 7292, Tours, France", 
            "Service de Rhumatologie, CHRU de Tours, Tours, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goupille", 
        "givenName": "Philippe", 
        "id": "sg:person.0775207643.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775207643.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire de Tours", 
          "id": "https://www.grid.ac/institutes/grid.411167.4", 
          "name": [
            "Universit\u00e9 Fran\u00e7ois-Rabelais de Tours, CNRS, UMR 7292, Tours, France", 
            "Service de Rhumatologie, CHRU de Tours, Tours, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bahuaud", 
        "givenName": "Cl\u00e9ment", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Fran\u00e7ois Rabelais University", 
          "id": "https://www.grid.ac/institutes/grid.12366.30", 
          "name": [
            "Universit\u00e9 Fran\u00e7ois-Rabelais de Tours, CNRS, UMR 7292, Tours, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sung", 
        "givenName": "Hsueh Cheng", 
        "id": "sg:person.0670656505.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0670656505.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire de Tours", 
          "id": "https://www.grid.ac/institutes/grid.411167.4", 
          "name": [
            "Universit\u00e9 Fran\u00e7ois-Rabelais de Tours, CNRS, UMR 7292, Tours, France", 
            "Laboratoire d\u2019Immunologie, CHRU de Tours, Tours, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Watier", 
        "givenName": "Herv\u00e9", 
        "id": "sg:person.01303233136.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01303233136.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire de Tours", 
          "id": "https://www.grid.ac/institutes/grid.411167.4", 
          "name": [
            "Universit\u00e9 Fran\u00e7ois-Rabelais de Tours, CNRS, UMR 7292, Tours, France", 
            "Laboratoire d\u2019Immunologie, CHRU de Tours, Tours, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Thibault", 
        "givenName": "Gilles", 
        "id": "sg:person.01001566717.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001566717.64"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1002/art.23902", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002362166"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/ar2798", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003973730", 
          "https://doi.org/10.1186/ar2798"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3899/jrheum.120573", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007610554"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.23473", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008890052"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.22025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011785477"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.22019", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012918194"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.21617", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014836446"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.21617", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014836446"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.30233", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017406353"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/ar2789", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019043114", 
          "https://doi.org/10.1186/ar2789"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/rheumatology/kep314", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032188590"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/rheumatology/kep314", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032188590"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.38107", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034262614"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.11181", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041275125"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa032534", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043728273"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00296-015-3295-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044127734", 
          "https://doi.org/10.1007/s00296-015-3295-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.1780390105", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050256920"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-12", 
    "datePublishedReg": "2016-12-01", 
    "description": "BACKGROUND: Significant peripheral blood CD4+ T-cell depletion has been observed after a first cycle of rituximab, a monoclonal antibody directed against the CD20 antigen, which is currently used in rheumatoid arthritis. Of note, an absence of CD4+ T-cell decrease has been observed in non-responders. Herein, we describe CD4+ T-cell changes over repeated cycles of rituximab and their relationship with clinical outcomes.\nMETHODS: Patients with rheumatoid arthritis who started rituximab between July 2007 and July 2013 were analyzed up to November 2014. Lymphocyte phenotyping and clinical assessments were performed before, and 3 and 6\u00a0months after each cycle. Lymphocytes counts and disease activity were compared at each time point, using nonparametric tests.\nRESULTS: Patients received up to seven cycles of treatment during the study period. Mean CD4+ T-cell counts were above the upper limit of the reference range before each rituximab infusion and repeatedly reached the reference range at 6\u00a0months (and/or 3\u00a0months) post infusion. CD4+ T cells decreased concurrently with disease activity score.\nCONCLUSIONS: CD4+ T-cell counts could be a relevant biomarker of response to rituximab in rheumatoid arthritis and could be considered in making decisions about the timing of retreatment.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s13075-016-1152-5", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1297499", 
        "issn": [
          "1478-6354", 
          "1478-6362"
        ], 
        "name": "Arthritis Research & Therapy", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "18"
      }
    ], 
    "name": "Repeated decrease of CD4+ T-cell counts in patients with rheumatoid arthritis over multiple cycles of rituximab treatment", 
    "pagination": "253", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "0703734da551bbeb13300fcb8fc0fea69abeed2d6f4ca18cea02834d4d9dcec7"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27793209"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101154438"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s13075-016-1152-5"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1001472369"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s13075-016-1152-5", 
      "https://app.dimensions.ai/details/publication/pub.1001472369"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:27", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000362_0000000362/records_87119_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs13075-016-1152-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13075-016-1152-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13075-016-1152-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13075-016-1152-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13075-016-1152-5'


 

This table displays all metadata directly associated to this object as RDF triples.

220 TRIPLES      21 PREDICATES      58 URIs      35 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s13075-016-1152-5 schema:about N0ad6441c6aef425b8b68f86b5c96eaeb
2 N0c300989495f442886528909077b205a
3 N13efc7b36555472388ec88ba915cd08c
4 N197ba48cd5b8441cbb0528df87c35965
5 N2ebdfaccfea64570a1a39af955efc706
6 N4640dc1e81fc4d9aafe26f4acf60abd2
7 N6fd22bde0cbe4d228e78ea6eae4f1e93
8 N774025e7ef9f45cbb7c5370c59b566e5
9 N833b69cd6de24898b9bfd9ec0b9f2b91
10 N9e7265ce232b4ccf9457318734540692
11 Naf139683ee5f4ee1bdf1035d84b7a34c
12 Nd58a64d8f77e4ec895e26c4ad5560157
13 Ndeb80e42057f4865ab1f40bffb13cfe6
14 Ne4cf04c073fe4b7ab5f6fcce00417ba3
15 anzsrc-for:11
16 anzsrc-for:1103
17 schema:author N7c93c6ed81744b2e9f65d70e47d90319
18 schema:citation sg:pub.10.1007/s00296-015-3295-0
19 sg:pub.10.1186/ar2789
20 sg:pub.10.1186/ar2798
21 https://doi.org/10.1002/art.11181
22 https://doi.org/10.1002/art.1780390105
23 https://doi.org/10.1002/art.21617
24 https://doi.org/10.1002/art.22019
25 https://doi.org/10.1002/art.22025
26 https://doi.org/10.1002/art.23473
27 https://doi.org/10.1002/art.23902
28 https://doi.org/10.1002/art.30233
29 https://doi.org/10.1002/art.38107
30 https://doi.org/10.1056/nejmoa032534
31 https://doi.org/10.1093/rheumatology/kep314
32 https://doi.org/10.3899/jrheum.120573
33 schema:datePublished 2016-12
34 schema:datePublishedReg 2016-12-01
35 schema:description BACKGROUND: Significant peripheral blood CD4+ T-cell depletion has been observed after a first cycle of rituximab, a monoclonal antibody directed against the CD20 antigen, which is currently used in rheumatoid arthritis. Of note, an absence of CD4+ T-cell decrease has been observed in non-responders. Herein, we describe CD4+ T-cell changes over repeated cycles of rituximab and their relationship with clinical outcomes. METHODS: Patients with rheumatoid arthritis who started rituximab between July 2007 and July 2013 were analyzed up to November 2014. Lymphocyte phenotyping and clinical assessments were performed before, and 3 and 6 months after each cycle. Lymphocytes counts and disease activity were compared at each time point, using nonparametric tests. RESULTS: Patients received up to seven cycles of treatment during the study period. Mean CD4+ T-cell counts were above the upper limit of the reference range before each rituximab infusion and repeatedly reached the reference range at 6 months (and/or 3 months) post infusion. CD4+ T cells decreased concurrently with disease activity score. CONCLUSIONS: CD4+ T-cell counts could be a relevant biomarker of response to rituximab in rheumatoid arthritis and could be considered in making decisions about the timing of retreatment.
36 schema:genre research_article
37 schema:inLanguage en
38 schema:isAccessibleForFree true
39 schema:isPartOf N04f88c301aab49ea8dfaedb9dcfa8941
40 N1358743128d0432ca10b7aea151180ae
41 sg:journal.1297499
42 schema:name Repeated decrease of CD4+ T-cell counts in patients with rheumatoid arthritis over multiple cycles of rituximab treatment
43 schema:pagination 253
44 schema:productId N27ec3328ae3f48f68f4a912aa148e638
45 N408be73dc5f049a2b6c732e62b363ed4
46 N46a95af51905451d94e110b784c1fcd7
47 N5c423cfd48514b6890312b56b7ec95a1
48 Nad4fc356bfab4a9480d3e78a578b858b
49 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001472369
50 https://doi.org/10.1186/s13075-016-1152-5
51 schema:sdDatePublished 2019-04-11T12:27
52 schema:sdLicense https://scigraph.springernature.com/explorer/license/
53 schema:sdPublisher N23a9d75f6a1f487794cea473a4d3d30f
54 schema:url https://link.springer.com/10.1186%2Fs13075-016-1152-5
55 sgo:license sg:explorer/license/
56 sgo:sdDataset articles
57 rdf:type schema:ScholarlyArticle
58 N04f88c301aab49ea8dfaedb9dcfa8941 schema:volumeNumber 18
59 rdf:type schema:PublicationVolume
60 N0a902b88f79e4c8ead57e0e0e4e0fa49 schema:affiliation https://www.grid.ac/institutes/grid.411167.4
61 schema:familyName Bahuaud
62 schema:givenName Clément
63 rdf:type schema:Person
64 N0ad6441c6aef425b8b68f86b5c96eaeb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
65 schema:name Middle Aged
66 rdf:type schema:DefinedTerm
67 N0c300989495f442886528909077b205a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name Antirheumatic Agents
69 rdf:type schema:DefinedTerm
70 N1358743128d0432ca10b7aea151180ae schema:issueNumber 1
71 rdf:type schema:PublicationIssue
72 N13efc7b36555472388ec88ba915cd08c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Aged
74 rdf:type schema:DefinedTerm
75 N197ba48cd5b8441cbb0528df87c35965 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Flow Cytometry
77 rdf:type schema:DefinedTerm
78 N23a9d75f6a1f487794cea473a4d3d30f schema:name Springer Nature - SN SciGraph project
79 rdf:type schema:Organization
80 N27ec3328ae3f48f68f4a912aa148e638 schema:name readcube_id
81 schema:value 0703734da551bbeb13300fcb8fc0fea69abeed2d6f4ca18cea02834d4d9dcec7
82 rdf:type schema:PropertyValue
83 N2ebdfaccfea64570a1a39af955efc706 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Male
85 rdf:type schema:DefinedTerm
86 N2f76f9c5da5240d5bbf20be7ee2dd2f3 rdf:first sg:person.0670656505.18
87 rdf:rest N92dd94a73d204b529ed7b26b542b2fbb
88 N408be73dc5f049a2b6c732e62b363ed4 schema:name nlm_unique_id
89 schema:value 101154438
90 rdf:type schema:PropertyValue
91 N4640dc1e81fc4d9aafe26f4acf60abd2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name CD4-Positive T-Lymphocytes
93 rdf:type schema:DefinedTerm
94 N46a95af51905451d94e110b784c1fcd7 schema:name pubmed_id
95 schema:value 27793209
96 rdf:type schema:PropertyValue
97 N4c9811af6069480186405ecf479bf842 rdf:first sg:person.01272504637.86
98 rdf:rest Ne4cae2773cae4de181fc3c680546f7e8
99 N5c423cfd48514b6890312b56b7ec95a1 schema:name dimensions_id
100 schema:value pub.1001472369
101 rdf:type schema:PropertyValue
102 N6fd22bde0cbe4d228e78ea6eae4f1e93 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Female
104 rdf:type schema:DefinedTerm
105 N774025e7ef9f45cbb7c5370c59b566e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Arthritis, Rheumatoid
107 rdf:type schema:DefinedTerm
108 N7c93c6ed81744b2e9f65d70e47d90319 rdf:first sg:person.011675334345.37
109 rdf:rest N4c9811af6069480186405ecf479bf842
110 N833b69cd6de24898b9bfd9ec0b9f2b91 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Adult
112 rdf:type schema:DefinedTerm
113 N92dd94a73d204b529ed7b26b542b2fbb rdf:first sg:person.01303233136.42
114 rdf:rest Na0b1466623c34c2283c46cad295179dc
115 N9e7265ce232b4ccf9457318734540692 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name CD4 Lymphocyte Count
117 rdf:type schema:DefinedTerm
118 Na0b1466623c34c2283c46cad295179dc rdf:first sg:person.01001566717.64
119 rdf:rest rdf:nil
120 Nad4fc356bfab4a9480d3e78a578b858b schema:name doi
121 schema:value 10.1186/s13075-016-1152-5
122 rdf:type schema:PropertyValue
123 Naf139683ee5f4ee1bdf1035d84b7a34c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Rituximab
125 rdf:type schema:DefinedTerm
126 Nb2469773612144669fd2469fe616cae3 rdf:first N0a902b88f79e4c8ead57e0e0e4e0fa49
127 rdf:rest N2f76f9c5da5240d5bbf20be7ee2dd2f3
128 Nd58a64d8f77e4ec895e26c4ad5560157 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Aged, 80 and over
130 rdf:type schema:DefinedTerm
131 Ndeb80e42057f4865ab1f40bffb13cfe6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Humans
133 rdf:type schema:DefinedTerm
134 Ne4cae2773cae4de181fc3c680546f7e8 rdf:first sg:person.0775207643.18
135 rdf:rest Nb2469773612144669fd2469fe616cae3
136 Ne4cf04c073fe4b7ab5f6fcce00417ba3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Retrospective Studies
138 rdf:type schema:DefinedTerm
139 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
140 schema:name Medical and Health Sciences
141 rdf:type schema:DefinedTerm
142 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
143 schema:name Clinical Sciences
144 rdf:type schema:DefinedTerm
145 sg:journal.1297499 schema:issn 1478-6354
146 1478-6362
147 schema:name Arthritis Research & Therapy
148 rdf:type schema:Periodical
149 sg:person.01001566717.64 schema:affiliation https://www.grid.ac/institutes/grid.411167.4
150 schema:familyName Thibault
151 schema:givenName Gilles
152 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001566717.64
153 rdf:type schema:Person
154 sg:person.011675334345.37 schema:affiliation https://www.grid.ac/institutes/grid.411167.4
155 schema:familyName Lavielle
156 schema:givenName Matthieu
157 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011675334345.37
158 rdf:type schema:Person
159 sg:person.01272504637.86 schema:affiliation https://www.grid.ac/institutes/grid.411167.4
160 schema:familyName Mulleman
161 schema:givenName Denis
162 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272504637.86
163 rdf:type schema:Person
164 sg:person.01303233136.42 schema:affiliation https://www.grid.ac/institutes/grid.411167.4
165 schema:familyName Watier
166 schema:givenName Hervé
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01303233136.42
168 rdf:type schema:Person
169 sg:person.0670656505.18 schema:affiliation https://www.grid.ac/institutes/grid.12366.30
170 schema:familyName Sung
171 schema:givenName Hsueh Cheng
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0670656505.18
173 rdf:type schema:Person
174 sg:person.0775207643.18 schema:affiliation https://www.grid.ac/institutes/grid.411167.4
175 schema:familyName Goupille
176 schema:givenName Philippe
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775207643.18
178 rdf:type schema:Person
179 sg:pub.10.1007/s00296-015-3295-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044127734
180 https://doi.org/10.1007/s00296-015-3295-0
181 rdf:type schema:CreativeWork
182 sg:pub.10.1186/ar2789 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019043114
183 https://doi.org/10.1186/ar2789
184 rdf:type schema:CreativeWork
185 sg:pub.10.1186/ar2798 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003973730
186 https://doi.org/10.1186/ar2798
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1002/art.11181 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041275125
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1002/art.1780390105 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050256920
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1002/art.21617 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014836446
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1002/art.22019 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012918194
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1002/art.22025 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011785477
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1002/art.23473 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008890052
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1002/art.23902 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002362166
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1002/art.30233 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017406353
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1002/art.38107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034262614
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1056/nejmoa032534 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043728273
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1093/rheumatology/kep314 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032188590
209 rdf:type schema:CreativeWork
210 https://doi.org/10.3899/jrheum.120573 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007610554
211 rdf:type schema:CreativeWork
212 https://www.grid.ac/institutes/grid.12366.30 schema:alternateName François Rabelais University
213 schema:name Université François-Rabelais de Tours, CNRS, UMR 7292, Tours, France
214 rdf:type schema:Organization
215 https://www.grid.ac/institutes/grid.411167.4 schema:alternateName Centre Hospitalier Universitaire de Tours
216 schema:name GICC – UMR 7292, UFR de Médecine, Bâtiment Vialle, 10 boulevard Tonnellé, BP 3223, 37032, Tours, Cedex 01, France
217 Laboratoire d’Immunologie, CHRU de Tours, Tours, France
218 Service de Rhumatologie, CHRU de Tours, Tours, France
219 Université François-Rabelais de Tours, CNRS, UMR 7292, Tours, France
220 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...